SWOG clinical trial number
SWOG-9120
Investigation of G-CSF and Trans-Retinoic Acid in the Treatment of Myelodysplastic Syndrome, Phase I
Closed
Phase
Accrual
23%
Abbreviated Title
Investigation of G-CSF and Trans-Retinoic Acid in the Treatment of Myelodysplastic Syndrome, Phase I
Activated
04/01/1993
Closed
07/01/1995